Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Author:

Garassino Marina Chiara,Cho Byoung-Chul,Kim Joo-Hang,Mazières Julien,Vansteenkiste Johan,Lena Hervé,Corral Jaime Jesus,Gray Jhanelle E,Powderly John,Chouaid Christos,Bidoli Paolo,Wheatley-Price Paul,Park Keunchil,Soo Ross A,Huang Yifan,Wadsworth Catherine,Dennis Phillip A,Rizvi Naiyer A,Paz-Ares Rodriguez Luis,Novello Silvia,Hiret Sandrine,Schmid Peter,Laack Eckart,Califano Raffaele,Maemondo Makoto,Kim Sang-We,Chaft Jamie,Vicente Baz David,Berghmans Thierry,Kim Dong-Wan,Surmont Veerle,Reck Martin,Han Ji-Youn,Holgado Martin Esther,Belda Iniesta Cristobal,Oe Yuichiro,Chella Antonio,Chopra Akhil,Robinet Gilles,Soto Parra Hector,Thomas Michael,Cheema Parneet,Katakami Nobuyuki,Su Wu-Chou,Kim Young-Chul,Wolf Juergen,Lee Jong-Seok,Saka Hideo,Milella Michele,Ramos Garcia Inmaculada,Sibille Anne,Yokoi Takashi,Kang Eun Joo,Atagi Shinji,Spaeth-Schwalbe Ernst,Nishio Makoto,Imamura Fumio,Gabrail Nashat,Veillon Remi,Derijcke Sofie,Maeda Tadashi,Zylla Dylan,Kubiak Kendra,Santoro Armando,Uy Ma. Noemi,Lucien Geater Sarayut,Italiano Antoine,Kowalski Dariusz,Barlesi Fabrice,Chen Yuh-Min,Spigel David,Chewaskulyong Busyamas,Garcia Gomez Ramon,Alvarez Alvarez Rosa,Yang Chih-Hsin,Hsia Te-Chun,Denis Fabrice,Sakai Hiroshi,Vincent Mark,Goto Koichi,Bosch-Barrera Joaquim,Weiss Glen,Canon Jean-Luc,Scholz Christian,Aglietta Massimo,Kemmotsu Hirotsugu,Azuma Koichi,Bradbury Penelope,Feld Ronald,Chachoua Abraham,Jassem Jacek,Juergens Rosalyn,Palmero Sanchez Ramon,Malcolm Albert,Vrindavanam Nandagopal,Kubota Kaoru,Waller Cornelius,Waterhouse David,Coudert Bruno,Mark Zsuzsanna,Satouchi Miyako,Chang Gee-Chen,Herzmann Christian,Chaudhry Arvind,Giridharan Selvaraj,Hesketh Paul,Ikeda Norihiko,Boccia Ralph,Iannotti Nichola,Haigentz Missak,Reynolds John,Querol John,Nakagawa Kazuhiko,Sugawara Shunichi,Tan Eng Huat,Hirashima Tomonori,Gettinger Scott,Kato Terufumi,Takeda Koji,Juan Vidal Oscar,Mohn-Staudner Andrea,Panwalkar Amit,Daniel Davey,Kobayashi Kunihiko,Ladrera Guia Elena Imelda,Schulte Clemens,Sebastian Martin,Cernovska Marketa,Coupkova Helena,Havel Libor,Pauk Norbert,Singh Joginder,Murakami Shuji,Csoszi Tibor,Losonczy Gyorgy,Price Allan,Anderson Ian,Iqbal Mussawar,Torri Vamsee,Juhasz Erzsebet,Khanani Saleem,Koubkova Leona,Levy Benjamin,Page Ray,Bocskei Csaba,Crinò Lucio,Einspahr David,Hagenstad Christopher,Juat Necy,Overton Lindsay,Garrison Mitchell,Szalai Zsuzsanna

Publisher

Elsevier BV

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3